Title |
Shorter epilepsy duration is associated with better seizure outcome in temporal lobe epilepsy surgery
|
---|---|
Published in |
Arquivos de Neuro-Psiquiatria, March 2015
|
DOI | 10.1590/0004-282x20140230 |
Pubmed ID | |
Authors |
Lucas Crociati Meguins, Rodrigo Antônio Rocha da Cruz Adry, Sebastião Carlos da Silva-Junior, Gerardo Maria de Araújo, Lúcia Helena Neves Marques |
Abstract |
Objective To investigate the influence of patient's age and seizure onset on surgical outcome of temporal lobe epilepsy (TLE). Method A retrospective observational investigation performed from a cohort of patients from 2000 to 2012. Results A total of 229 patients were included. One-hundred and eleven of 179 patients (62%) were classified as Engel I in the group with < 50 years old, whereas 33 of 50 (66%) in the group with ≥ 50 years old group (p = 0.82). From those Engel I, 88 (61%) reported epilepsy duration inferior to 10 years and 56 (39%) superior to 10 years (p < 0.01). From the total of patients not seizure free, 36 (42%) reported epilepsy duration inferior to 10 years and 49 (58%) superior to 10 years (p < 0.01). Conclusion Patients with shorter duration of epilepsy before surgery had better postoperative seizure control than patients with longer duration of seizures. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Turkey | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Ethiopia | 1 | 3% |
Unknown | 35 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 17% |
Other | 5 | 14% |
Student > Bachelor | 5 | 14% |
Student > Postgraduate | 4 | 11% |
Student > Ph. D. Student | 4 | 11% |
Other | 5 | 14% |
Unknown | 7 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 47% |
Agricultural and Biological Sciences | 2 | 6% |
Neuroscience | 2 | 6% |
Psychology | 2 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Other | 3 | 8% |
Unknown | 9 | 25% |